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Abstract – Toll-like receptors (TLR) are highly conserved pattern recognition receptors of the innate
immune system. Toll-like receptor 2 (TLR2) recognizes bacterial lipopeptides in a heterodimeric complex
with TLR6 or TLR1, thereby discriminating between di- or triacylated lipopeptides, respectively.
Previously, we found that HEK293 cells transfected with bovine TLR2 (boTLR2) were able to respond to
diacylated lipopeptides but did not recognize triacylated lipopeptides, even after cotransfection with the so
far published sequence of boTLR1. In this study we now could show that primary bovine cells were
in general able to detect triacylated lipopetides. A closer investigation of the boTLR1 gene locus revealed an
additional ATG 195 base pairs upstream from the published start codon. Its transcription would result in an
N-terminus with high identity to human and murine TLR1 (huTLR1, muTLR1). Cloning and cotransfection
of this longer boTLR1 with boTLR2 now resulted in the recognition of triacylated lipopeptides by HEK293
cells, thereby resembling the ex vivo observation. Analysis of the structure-activity relationship showed that
the ester-bound acid chains of these lipopeptides need to consist of at least 12 carbon atoms to activate the
bovine heterodimer showing similarity to the recognition by huTLR2/huTLR1. In contrast, HEK293 cell
cotransfected with muTLR2 and muTLR1 could already be activated by lipopeptides with shorter fatty acids
of only 6 carbon atoms. Thus, our data indicate that the additional N-terminal nucleotides belong to the full
length and functionally active boTLR1 (boTLR1-ﬂ) which participates in a species-speciﬁc recognition of
bacterial lipopeptides.
toll-like receptor / bacterial lipopeptide / species-speciﬁcity
1. INTRODUCTION
A prerequisite for the induction of an
immune response against invading pathogens
is the recognition of their presence. To discrim-
inate between self and non-self the immune sys-
tem has evolved a repertoire of germline-
encoded so called pattern recognition receptors
(PRR) which recognize highly conserved path-
ogen associated molecular patterns (PAMP)
present on all microorganisms [16]. A promi-
nent family of PRR is that of toll-like receptors
(TLR) which have been found in most inverte-
brates and all vertebrate species [24]. In mam-
mals there are so far 13 different TLR
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and 13 natural ligands are known for all TLR
allowing the immune system to detect nearly
all kinds of invading microorganisms [2, 22].
TLR are type I transmembrane receptors
composed of an extracellular domain consisting
of 19–25 leucine-rich repeats (LRR), a trans-
membrane domain and an intracellular toll/
interleukin 1 receptor (TIR) domain [12]. The
TIR domain is highly conserved between
TLR and different species and mediates the
induction of signal transduction cascades via
MyD88 and/or as found with TLR3 and
TLR4 via TRIF [7]. Ligand binding occurs
via the LRR of the ectodomain. For this reason
this domain highly varies between different
TLR but shares great similarity between the
same TLR of different species [24]. Neverthe-
less there are some species-speciﬁc differences
in the ligand recognition [31].
While all other TLR are active as homodi-
mers TLR2 is unique in its ability to form func-
tional active heterodimers with either TLR1 or
TLR6 [27]. Although this receptor is thought
to recognize the most diverse repertoire of
structural different ligands like lipoteichoic
acids, peptidoglycan and endogenous ligands
like heat shock proteins and hyaluronic acid,
the best characterized (and maybe only) ligands
are bacterial lipoproteins [34]. Lipoproteins rep-
resent an important constituent of the cell wall
of Gram-positive and Gram-negative bacteria
and are also present on the membrane of myco-
plasma [1]. All lipoproteins are composed of a
conserved N-terminal dihydroxypropyl cysteine
w h i c hc a nb ea c y l a t e dw i t h2o r3f a t t ya c i d s
that anchor the protein to the cell membrane
[32]. By generating synthetic lipopeptides the
structure-activity relationship has extensively
been studied in human and murine cells. Beside
the number and length of the fatty acids also the
N-terminal amino acids of lipoproteins are
responsible for the ligand-receptor interaction
on host cells [4, 21]. Taken together, most dia-
cylated lipopeptides activate TLR2/6 heterodi-
mers, while most triacylated lipopeptides are
recognized by TLR2/1 heterodimers [3, 21,
23, 28, 29]. However, some di- and triacylated
lipopeptides seem to be recognized by both,
TLR2/1 and TLR2/6 heterodimers [5, 21].
The activation of TLR2/1 and/or TLR2/6 het-
erodimers then leads to similar or even identical
signalling-pathways indicating that this hetero-
dimerization broadens the ligand spectrum (di-
and triacylated lipopeptides) rather than to
mediate different immune responses [8].
Species-speciﬁc recognition of lipopeptides
has been found using murine and human cells
where lipopeptides with short-length fatty acids
activate muTLR2 heterodimers whereas human
receptors require longer acid chains like pal-
mitic acids [13]. Recently we have established
HEK293 cell lines stably transfected with
bovine TLR (boTLR) – one with boTLR4
and boMD2 and one with boTLR2 – to
examine their contribution to the pathology of
bacteria causing diseases in cattle [9, 26].
Concerning boTLR2, we noticed that
HEK293 cells transfected only with this recep-
tor were able to recognize diacylated lipopep-
tides but could not be activated by triacylated
lipopeptides.
In this study we therefore have investigated
whether primary bovine cells in general and
HEK293-boTLR2 cells additionally transfected
with boTLR1 are able to recognize triacylated
lipopeptides. Furthermore, we have analyzed
the structural prerequisites of synthetic lipopep-
tides to activate bovine TLR2/TLR1 in compar-
ison to human and murine heterodimers to help
improving our understanding of the action of
species-speciﬁc pathogens.
2. MATERIALS AND METHODS
2.1. Reagents and plasmids
Dulbecco’s modiﬁed Eagle’s medium GIBCO-
LG (DMEM), penicillin-streptomycin (PS), L-gluta-
mine (LG), sodium pyruvate, and Hepes buffer were
obtained from Invitrogen (Karlsruhe, Germany).
Fetal calf serum (FCS) (Linaris, Wertheim-Bettingen,
Germany) was heat-inactivated. The synthetic LP
were synthesized and analyzed by EMC microcollec-
tions GmbH (Tu ¨bingen, Germany) and show strict
T L R 2d e p e n d e n c ya sd e t e r m i n e db yt h eu s eo f
TLR2-deﬁcient mice and TLR2 transfected
HEK293 cells (data not shown). The chemical struc-
tures, denotations and abbreviations of LP and fatty
acids used in this study are represented in
Vet. Res. (2010) 41:34 K. Farhat et al.
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1. Human recombinant
TNF-a w a sk i n d l yp r o v i d e db yP r o f .D .M a e n n e l
(University of Regensburg, Regensburg, Germany).
Plasmids of human and murine TLR were obtained
from InvivoGen (San Diego, USA). cDNA of bovine
TLR2 and short form of TLR1 was cloned into pCR
2.1-TOPO vector (Stratagene, La Jolla, USA) and
subcloned into pUNO (InvivoGen) and pTarget (Pro-
mega, Mannheim, Germany), respectively. Coding
sequences for generation of cDNA were obtained
from NCBI GenBank. Identiﬁed full length bovine
TLR1 covers nucleotides 871727–874106 on chro-
mosome 6 (NW_001495180.2) thereby starting with
the ATG 195 base pairs upstream of the published
start codon (EU006652). cDNA was cloned into
pENTR/D-TOPO and subcloned into pDEST47
using GATEWAY cloning system according to the
provider’s manual (Invitrogen, Leek, Netherlands).
The sequence of full length boTLR1 is now available
at NCBI GenBank databases under accession number
FJ147090.
2.2. Cell lines and cell culture
The human embryonic kidney cell line HEK293
(ECACC) was cultured in DMEM supplemented
with 10% FCS, 1% PS and 1% LG. Cells were
seeded at 0.5 · 10
6 and 0.3 · 10
6 cells/10 mL in
75 cm
3 ﬂasks and cultured at 37  C, 5% CO2 for 3
or 4 days, respectively. The bovine B lymphocyte cell
line BL3 was obtained from the Collection of Cell
Lines in Veterinary Medicine (Friedrich-Loefﬂer-
Institut, Greifswald-Insel-Riems). Cells were cultured
in DMEM supplemented with 10% FCS, 1% PS and
1 %L Ga n dp a s s a g e dt w i c eaw e e kw i t h1· 10
6 and
0.7 · 10
6 cells/10 mL in 75 cm
3 ﬂasks and cultured
at 37  C, 5% CO2 for 3 or 4 days, respectively.
2.3. Transient transfection and stimulation
of cell lines
HEK293 cells were seeded at 0.2 · 10
5 cells/
150 lL in 96-well culture dishes. After 24 h transfec-
tion was performed using Polyfect reagent according
to the provider’s instructions (Qiagen, Hilden,
Germany). Cells were then stimulated for 24 h with
indicated concentrations of LP ranging from 1 to
100 nM. Supernatants were analyzed for IL-8 pro-
duction using commercial enzyme-linked immunoab-
sorbant assays (ELISA, Biosource, CA, USA). BL3
cells were seeded at 1 · 10
5 cells/400 lLi n2 4 - w e l l
culture dishes and triplicates were stimulated after
24 h with 100 nM LP for 6 h. Cells were washed
once with cold PBS and combined for RNA-isolation
and cDNA-synthesis.
2.4. Preparation of bovine mononuclear
cells (MNC) and spleen cells
Peripheral blood and spleen were obtained from
two healthy Holstein cows. MNC were separated
from heparinized blood diluted two-fold with phos-
phate-buffered saline (PBS) by gradient centrifuga-
tion (30 min, 4  C, 1 100 · g) in lymphocyte
separation medium (PAA Laboratories, Pasching,
Austria). The layer of MNC was recovered, washed
thrice in PBS and resuspended in DMEM supple-
mented with 10% FCS, 1% LG, 0.5% PS, 1% Hepes
and 1% sodium pyruvate. Spleen cells were mechan-
ically isolated using forceps and scalpel. Single cells
were separated from tissue fragments by sedimenta-
tion and washed thrice with DMEM containing
10% FCS, 1% LG, 0.5% PS, 1% Hepes and 1%
sodium pyruvate. All steps were performed on ice.
2.5. Stimulation of bovine MNC and spleen cells
MNC were seeded at 4 · 10
5 cells/300 lLp e r
48-well culture dish in supplemented DMEM. Tripli-
cates were stimulated with 100 nM LP for 6 h. Cells
were washed once with cold PBS before RNA-isola-
tion and cDNA-synthesis.
Isolated spleen cells were stimulated in triplicates
at 4 · 10
5/150 lL DMEM with 1, 10 and 100 nM
L Pf o r2 4 ha n dp u l s e dw i t h[
3H] thymidine
([
3H]TdR), 0.9 lCi/mL) for another 24 h of culture.
Cells were harvested and [
3H]TdR incorporation
determined in a liquid scintillation spectrometer.
The results are expressed in counts per minute per
culture [6].
2.6. RNA-isolation, cDNA-synthesis and PCR
RNA was isolated using Absolutely RNA Mini-
prep Kit including DNase digestion on column as
recommended by the manufacturer (Stratagene,
Amsterdam, Netherlands). One microgram of total
RNA was taken for cDNA-synthesis using Super-
Script III Reverse Transcriptase from Invitrogen
(Leek, Netherlands). Promega-PCR Mix was used
for ampliﬁcation of short (sense: CACCATGC
CTGACATCCTCTCAC; antisense: ATGTATTTC
TGCTGCTTTTTCC and full length boTLR1 (sense:
CACCATGACTAAAAAAAATTCTAGC; antisense:
1 Supplementary ﬁgures are available on line at
www.vetres.org.
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was performed with the Light Cycler 480 System
(Roche Diagnostics) using LightCycler
  Fast Start
DNA Master
PLUS according to the manufacturer’s
instructions. Relative cDNA amounts of IL-8 (sense:
CCTTTCCACCCCAAATTTATC, antisense: ACC
CACTTTTCCTTGG) were calculated compared to
the expression of the house-keeping gene HPRT
(sense: GGACTAATTATGGACAGG, antisense:
CCTTGAGCACACAGAGGG).
2.7. Sequence alignment and computation
Multiple alignment of DNA sequences and calcu-
lations of percentage identities were made using Clu-
stalW method in MegAline program of DNASTAR
software (DNASTAR, Inc., Madison, USA).
3. RESULTS
3.1. Recognition of di- and triacylated
lipopeptides by boTLR2-transfected
HEK293 cells
To examine which lipopeptide structures are
recognized by boTLR2 we stimulated HEK293
cells transfected with boTLR2 (HEK293-
boTLR2) with di- and triacylated forms of dif-
ferent lipopeptides (for structural details see
Supplementary Fig. S1
1). The responsiveness
was measured by IL-8 production (Fig. 1A)
and compared with HEK293 cells transfected
with human or murine TLR2 (Figs. 1B and
C). HEK293-boTLR2 cells only recognized di-
acylated lipopeptides as shown for Pam2C-FE-
PPPATTT (representing a synthetic LP of
Rhodopseudomonas viridis), Pam2C-SK4 and
Pam2C-GDPKHPKSF (representing a synthetic
LP of Mycoplasma salivarium;a l s on a m e d
FSL-1). The triacylated forms did not induce
any IL-8 release. In contrast, cells transfected
with huTLR2 or muTLR2 responded to both,
di- and triacylated lipopeptides. It should be
noted that the HEK293 cells used in this study
express native human TLR1 and TLR6 (Sup-
plementary Fig. S2
1). Therefore transfection
with huTLR2 leads to the formation of
TLR2/1 and TLR2/6 heterodimers and the rec-
ognition of tri- and diacylated lipopeptides,
respectively. MuTLR2 also seems to form
active heterodimers with the native human core-
ceptors. However, when transfected with
boTLR2 only diacylated lipopeptides were
recognized indicating a heterodimerization with
native human TLR6 but not with human TLR1.
3.2. Contribution of TLR1 to the recognition
of triacylated lipopeptides by boTLR2
Most triacylated lipopeptides activate the
cell through TLR2/1 heterodimers. For that rea-
son we cotransfected HEK293 cells with
boTLR2 and human or murine TLR1, or with
a vector containing the published sequence of
the boTLR1 (NCBI GenBank databases under
accession number EU006652). With 2 184 bp
its sequence is 183 and 204 bp shorter than
the human and murine ortholog, respectively.
Therefore, in the following it is termed
boTLR1-short (boTLR1-s, see Sect. 3.4).
Cotransfection of boTLR2 with boTLR1-s
did not result in an IL-8 release after stimulation
with Pam3C-SK4 (Fig. 2B). Also overexpres-
sion of huTLR1 had no inﬂuence on the recog-
nition of the triacylated stimulus (Fig. 2C).
Interestingly, in the presence of muTLR1 stim-
ulation with Pam3C-SK4 resulted in nearly the
same IL-8 release compared to stimulation with
Pam2C-SK4 did (Fig. 2D). This indicates that
boTLR2 forms a functional complex with
muTLR1 which can be activated via triacylated
lipopeptides.
3.3. Recognition of di- and triacylated
lipopeptides by bovine primary cells
and BL3 cell line
The recombinant boTLR1-s may differ from
native boTLR1. We therefore investigated,
whether triacylated lipopeptides are recognized
by native bovine cells. Bovine spleen cells,
MNC as well as the bovine B-cell line BL3
were stimulated with different di- and triacylat-
ed lipopeptides. As shown in Figure 3A all lipo-
peptides induced a dose-dependent B cell
proliferation in freshly isolated spleen cells.
While di- and triacylated lipopeptides with
FEPPPATTT and SK4 peptide tails were active
between 10 nM and 100 nM, the mitogenic
activity of Pam2C- and Pam3C-GDPKHPKSF
Vet. Res. (2010) 41:34 K. Farhat et al.
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Pam2C-FEPPPATTT and Pam2C-SK4 induced
slightly stronger proliferation compared to their
triacylatedanalogues.Neverthelessalltriacylated
structures were able to activate these cells.
Also in primary MNC and the BL3 cell line,
di- and triacylated lipopeptides were recognized
as shown for Pam2C-SK4 and Pam3C-SK4 by
induction of IL-8 mRNA (Figs. 3B and C).
Thus, bovine cells have in principle the ability
to react to triacylated lipopeptides.
3.4. Sequence comparison of bovine, human
and murine TLR1
The published nucleotide sequence of
boTLR1-s encompassed 2 184 bp (NCBI
GenBank databases under accession number
EU006652). Interestingly, 195 bp prior to the
published start codon we found another ATG in
the gene locus of boTLR1 (now published in
NCBI GenBank databases under accession num-
ber NW_001495180.2, Nucleotides 871727–
874106). An alignment with the sequence of
human and murine TLR1 revealed that the
boTLR1-s exhibits an N-terminus that is 183 to
204 bp shorter (Supplementary Fig. S3
1).
However, usage of the other ATG would result
in a longer receptor (boTLR1-full length) with a
nucleotide sequence that shares high homology
with the N-terminus of the human and murine
T L R 1( S u p p l e m e n t a r yF i g .S 2
1, boTLR1-ﬂ).
Also on protein level the ﬁrst 100 amino acids
would be 77% identical to huTLR1 and 57%
Figure 1. HEK293 cells transfected with boTLR2 do not recognize triacylated LP while human or murine
heterodimers were activated by these stimuli. HEK293 cells were transfected with (A) boTLR2 (B) huTLR2
or (C) muTLR2 and stimulated after 24 h with 100 nM of di- and triacylated LP with the peptide moieties
FEPPPATTT, SK4 or GDPKHPKSF. After 24 h IL-8 production was detected in the supernatant. Values are
means ± SD of n = 2 and represent the result of at least 3 independent experiments.
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that this sequence could be part of a full length
boTLR1 (boTLR1-ﬂ).
3.5. Ampliﬁcation of full length boTLR1
in primary bovine cells
Both, full length boTLR1 of 2 379 bp as
well as boTLR1-s (2 184 bp) could be detected
via RT-PCR in the cDNA of primary spleen
cells, MNC and BL3 cells (Fig. 4). Both prod-
ucts were of comparable intensity, leading to
the assumption that both primer pairs use the
cDNA of full length boTLR1 as template. This
postulation could be conﬁrmed using real-time
PCR where CT values for boTLR1-s and
boTLR1-ﬂ were equal (data not shown).
3.6. Recognition of triacylated lipopeptides
by boTLR2-transfected HEK293 cells
cotransfected with full length boTLR1
BoTLR1-ﬂ was cloned and cotransfected
with boTLR2 into HEK293 cells and compared
with cells cotransfected with boTLR2 and
boTLR1-s. BoTLR2 in combination with
Figure 2. Cotransfection of boTLR2 with muTLR1 but not with bovine or human TLR1 resulted in the
recognition of triacylated LP. HEK293 cells were transfected with (A) boTLR2 alone or in combination with
(B) boTLR1-s, (C) huTLR1 or (D) muTLR1. Cells were stimulated for 24 h with 100 nM of Pam2C-SK4 or
Pam3C-SK4. IL-8 production was measured in the supernatant. Values are means ± SD of n = 2 and
represent the result of at least 3 independent experiments.
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peptides as shown by the inability of Pam3C-
SK4 to induce IL-8, while stimulation with
the diacylated Pam2C-SK4 induced a cytokine
release (Fig. 5, black bars). In contrast,
HEK293 cells that were cotransfected with
boTLR2 and boTLR1-ﬂ, could be activated
by both di- and triacylated lipopeptides (Fig. 5,
grey bars). We therefore concluded that
boTLR1-f1 is the true full length TLR1 which
is able to form functional heterodimers with
boTLR2. This boTLR2/1-ﬂ is responsible for
the recognition of triacylated lipopeptides like
in other species.
3.7. Impact of ester-bound fatty acids
of triacylated lipopeptides on their
recognition by bovine, human and
murine TLR2/1 heterodimers
By using a lipopeptide collection with differ-
ent acylation patterns we compared the
Figure 3. Primary bovine spleen cells, MNC and BL3 cells respond to both, di- and triacylated LP.
(A) Bovine spleen cells were stimulated for 24 h with 1, 10 and 100 nM of di- and triacylated LP with the
peptide moieties FEPPPATTT, SK4 or GDPKHPKSF. Activation was measured by [
3H]TdR incorporation
into the B-lymphocytes and results are expressed in counts per minute per culture. Values are means ± SD
of n = 3 and represent the result of 3 independent experiments. (B) Primary bovine MNC and (C) BL3 cells
were stimulated for 24 h with 100 nM of Pam2C-SK4 or Pam3C-SK4. IL-8 induction was determined on
mRNA level by real-time PCR normalized to the house-keeping gene HPRT. The results are representative
for at least 3 independent experiments.
Figure 4. Long form of boTLR1 can be detected in primary bovine spleen cells, MNC and BL3 cells.
RT-PCR with primer against the published boTLR1 (boTLR1-s) and the full length form (boTLR1-ﬂ)
ampliﬁed both TLR1 variants in cDNA from primary bovine spleen cells, MNC and BL3 cells.
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tides to activate the bovine TLR2/1-ﬂ heterodi-
m e ri nc o m p a r i s o nt ot h eh u m a na n dm u r i n e
receptors. All lipopeptides consist of the con-
served dihydroxypropyl cystein backbone con-
jugated with an amid-bound palmitic acid and
the peptide sequence SSNASK4. The chain
length of the ester-bound fatty acids increased
from 6 to 18 carbon atoms (hexanoic acids to
oleicacids;fordetailsseeonlineSupplementary
Fig. S1
1). Again, boTLR2 alone was not able to
recognize any of the triacylated lipopeptides
(Fig. 6A, black bars). Cotransfection of
boTLR1-ﬂ resulted in a reasonable recognition
of lipopeptides with ester-bound fatty acids of at
least 12 carbon atoms (dodecanoic acids). Lipo-
peptides with shorter fatty acids were not able
to induce an IL-8 release (Fig. 6A,g r e yb a r s ) .
In contrast, the huTLR2/1 heterodimer could
only be activated by lipopeptides with ester-
bound myristic acids (14 carbon atoms,
Fig. 6B, black bars) or fatty acids with a higher
number of carbon atoms. Additional overex-
pression of huTLR1 did not considerably
increase the IL-8 release after stimulation
(Fig. 6B, grey bars).
When transfected alone, muTLR2 was able
to recognize lipopeptides with ester-bound
dodecanoic acids (Fig. 6C, black bars). Cotrans-
fection with muTLR1 resulted in the response
to lipopeptides with short ester-bound hexanoic
acids as obtained with PamHex2C-SSNASK4.
Additionally, it should be noted, that the
cotransfection markedly enhanced the response
towards lipopeptides that were recognized by
cells transfected with muTLR2 alone (Fig. 6C,
grey bars). The longer the chain length the
higher was the induction of IL-8 with a maxi-
mal stimulation with lipopeptides possessing
dodecanoic acids. Lipopeptides with longer
fatty acids had no stronger stimulatory
activity.
4. DISCUSSION
In our previous study we could show, that
HEK293 cells stably transfected with boTLR2
were able to respond to Staphylococcus aureus,
heat-killed Listeria monocytogenes (HKLM),
Escherichia coli causing mastitis (strain JF
4.037) and to different diacylated lipopeptides
[9]. The aim of the present study now was to
understand in more detail the requirements of
the boTLR2-coreceptor boTLR1 for the recog-
nition of triacylated lipopeptides.
The HEK293 cells used in this study express
native human TLR1 and TLR6 but no TLR2
(Supplementary Fig. S3
1). Hence, transfection
of huTLR2 enables the cells to recognize all
kinds of biologically active lipopeptides
(Fig. 1B). The fact that muTLR2 transfected
cells are also able to respond to the tested di-
and triacylated lipopeptides (Fig. 1C)i n d i c a t e s
that the murine receptor forms functionally
active heterodimers with huTLR6 and at least
partially with huTLR1.
In contrast to muTLR2, our data indicate
that boTLR2 forms only active heterodimers
with huTLR6 but not with huTLR1, as deter-
mined by the responsiveness to diacylated but
not to triacylated lipopeptides (Figs. 1A and
2C). However, HEK293 cells cotransfected
with boTLR2 and muTLR1 induced an IL-8
response when stimulated with Pam3C-SK4.
This response was comparable to that of
Pam2C-SK4 stimulated cells (Fig. 2D). The
overall sequence identity of human and murine
Figure 5. Cotransfection of boTLR2 with full
length boTLR1 resulted in the recognition of
triacylated LP. HEK293 cells were transfected with
boTLR2 in combination with short boTLR1 (black
bars) or full length boTLR1 (grey bars). Cells were
stimulated for 24 h with 10 ng/mL TNF-a and
100 nM of the lipopeptides Pam2C-SK4 and
Pam3C-SK4. IL-8 production was measured in the
supernatant. Values are means ± SD of n = 2 and
represent the result of at least 3 independent
experiments.
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respectively. The identity between human and
bovine TLR1 and TLR6 is even higher
(78.2% and 78.7%, respectively) and also
TLR2 between these species shares 77% iden-
tity compared to 70.6% between huTLR2 and
muTLR2. However, to explain the observation
that boTLR2 forms functionally active heterodi-
mers with muTLR1 but not with huTLR1, more
detailed comparisons of the sequences and
structures of the TLR of the different species
are necessary. There are already studies apply-
ing site-directed mutagenesis, chimeras or crys-
tal structures and modeling showing that
distinct amino acids sequences are involved in
the direct interaction between TLR2 and its co-
receptors [10, 17, 25].
Because boTLR2/muTLR1 heterodimers
were functionally active, it was surprising that
the cotransfection of HEK293 cells with
Figure 6. Structure-activity relationship of triacylated lipopeptides of HEK293 cells transfected with
bovine, human or murine TLR2 alone or in combination with respective TLR1. HEK293 cells were
transfected with (A) bovine, (B) human or (C) murine TLR2 alone (black bars) or in combination with the
respective TLR1 (grey bars). Cells were stimulated for 24 h with 10 ng/mL TNF-a and 100 nM of the
indicated lipopeptides. Length of the ester-bound fatty acids increase from left to right. IL-8 production was
measured in the supernatant. Values are means ± SD of n = 2 and represent the result of at least 3
independent experiments.
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lished sequence of boTLR1 did not result in
recognition of triacylated lipopeptides, like
Pam3C-SK4 (Fig. 2B). On mRNA level we
detected the transcript of this boTLR1 in trans-
fected HEK293 cells (data not shown). Unfortu-
nately, there are no boTLR1 antibodies
available to investigate the protein expression,
hence, its cellular presence and localization
could not be conﬁrmed. To follow the hypoth-
esis that the so far published boTLR1 sequence
may be incomplete, we analyzed the TLR1
sequences of the different species and ﬁgured
out that the published sequence of the bovine
receptor is 59 and 68 amino acids shorter than
the human and murine TLR1, respectively,
thereby possessing a shortened N-terminus
(boTLR1-s, short). This led us to the assump-
tion that the missing N-terminus might be
responsible for the ﬁnding that triacylated
ligands, like Pam3C-SK4, could not activate
boTLR2/1-s transfected HEK293 cells.
We and others already showed that Gram-
negativebacteria,whichexpresstriacylatedlipo-
proteins,arerecognizedbynativebovinecellsin
a TLR2-dependent manner [9, 33]. We, there-
fore,expectedalso triacylated synthetic lipopep-
tides to activate native bovine cells. And indeed,
we could show that primary bovine cells and
bovine cell lines could respond to di- as well as
to triacylated ligands (Fig. 3). This again led us
to the assumption that the published sequence
of boTLR1 is incomplete and does not match
the sequence of native boTLR1.
In fact, by investigating the sequence and the
gene locus of boTLR1 more closely we found
an additional ATG 195 base pairs upstream
from the so far published start codon that was
further proven to be the transcriptional start of
the full length boTLR1 (boTLR1-ﬂ; Supple-
mentary Fig. S4
1).
After cloning the boTLR1-ﬂ and transfecting
this construct together with boTLR2, HEK293
cellswerenowabletoinduceanIL-8production
in response to triacylated lipopeptides (Fig. 5).
From this we can conclude that the N-terminal
amino acids are indispensable for a functionally
active boTLR1. Even though we transfected the
HEK293cellswiththesameamountsofboTLR2
and boTLR1-ﬂ plasmids we have no indication
whether boTLR2 and boTLR1-ﬂ need to be
expressed in similar amounts by the cells,
because there are no antibodies available to
check the expression on protein level.
Although different studies showed that the
amino acids which are involved in ligand bind-
ing, receptor interaction, and cellular distribu-
tion are mainly located at LRR 9–14, the
transmembrane domain, the TIR domain, and
the N-terminal part can also be important for
the shape of the ectodomain, thereby inﬂuenc-
ing the ligand binding or the cellular targeting
of the receptor [11, 18–20]. For example, muta-
tion of four glycosylation sites of huTLR2 leads
to its intracellular retention [30]. Also exchange
of two cysteines at position 30 and 36 into ser-
ines caused an intracellular localization of this
receptor thereby disabling the cell to recognize
bacterial lipopeptides [19]. Preliminary data
from computer-aided molecular modeling of
TLR1-s and TLR1-ﬂ indicate that beside the
extracellular part of TLR1 also the transmem-
brane and the TIR domain express a modiﬁed
conformation
2. This ﬁnding indicates that all
parts of the TLR1-molecule are affected by
the deletion of the N-terminus in TLR1-s,
which results in a not active molecule.
So far, lipopeptides used in this study were
all di- or tripalmitoylated. This modiﬁcation
represents one of the most abundant forms of
acylation found in lipoproteins of bacterial
membranes [15]. However, the composition of
bacterial cell walls is very diverse and many
kinds of acylation patterns of lipoproteins can
be found as described for the acylation pattern
of LPS [14]. Therefore, we used the lipopeptide
collectionshowninSupplementaryFigureS1A
1
to evaluate the activation of boTLR2/1-ﬂ by
different structures in comparison to the human
and murine heterodimers in HEK293 cells. Our
data show clear species-speciﬁc differences in
the recognition of these lipopeptides by the
different heterodimers (Fig. 6). While the
muTLR2/1 could already be activated with
lipopeptides with ester-bound hexanoic acid
residues the bovine and human receptor
complex recognized lipopeptides with longer
2 Werlin D., personal communication, Hatﬁeld,
UK.
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respectively. Therefore, it is likely that muTLR2
does form functionally less active complexes
with huTLR1 than with huTLR6 and cotrans-
f e c t i o nw i t hm u T L R 1r e s u l t e di nt h em a r k e d
enhancement of the response towards the triacy-
lated ligands. Our data show that the bovine
TLR2/1-heterodimer discriminates between
diverse acylated lipopeptides in a different
way compared to the human- and more pro-
nounced to murine TLR2/1. On this basis it
could be possible to explain species-speciﬁc
susceptibilities and to get hints on the co-evolu-
tion of hosts and their species-speciﬁc environ-
ment that lead to the discrimination between
pathogens and commensals [31].
Taken together, we ﬁrstly identiﬁed the full
length functionally active boTLR1 and deter-
mined some structural prerequisites of triacylat-
ed lipopeptides to stimulate the boTLR2/1-ﬂ
heterodimer. We further demonstrated a spe-
cies-speciﬁc recognition of triacylated lipopep-
tides by boTLR2/1-ﬂ in comparison to
muTLR2/1 and huTLR2/1. The characteriza-
tion of the structure-activity relationship and
generation of a HEK293 cell line stably
expressing boTLR2 and the full length TLR1
can hereafter improve our understanding of
the action of species-speciﬁc pathogens and will
represent a good tool to further explore and
characterize the interaction of TLR with bacte-
ria causing disease in cattle, e.g. mastitis.
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